Kidney & Urology Foundation of America
Kidney & Urology Foundation of America
SAVE THE DATE:
Support Walk the Walk
New York Walk the Walk

October 31, 2010 - Central Park
REGISTER ONLINE NOW!
join us on Facebook
Join KUFA today
and become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected!

 

Patient Resources


Therapeutic Areas: Oncology | Family Medicine

Adenocarcinoma Clinical Trials


A listing of Adenocarcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Huntsville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Huntsville : Clearview Cancer Institute Updated

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Arizona

Chandler :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Chandler :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Flagstaff : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Gilbert :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Glendale :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Hot Springs :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Jonesboro :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Mesa :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Phoenix : Mayo Clinic Arizona

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Phoenix :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Prescott Valley : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Scottsdale : Scottsdale Healthcare

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Scottsdale :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Scottsdale : Translational Genomics Research Institute (TGen)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Scottsdale : Mayo Clinic Arizona (Site 229) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Scottsdale : Scottsdale Healthcare Research Institute

A clinical trial to evaluate treatments using MMB, Capecitabine and Oxaliplatin for patients with Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

Scottsdale : Mayo Clinic Arizona

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Scottsdale :

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Tucson : Arizona Clinical Research Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Tucson : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tucson : Arizona Cancer Center at University Medical Center North

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Tucson :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Arkansas

Fayetteville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Fayetteville : Highlands Oncology Group Updated

Patients are needed to participate in a clinical research study to evaluate Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Hot Springs : Genesis Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

California

Anaheim : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bakersfield :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Corona : Comprehensive Cancer Care Medical Group, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Corona :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Duarte :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Duarte : City of Hope, Site #009 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Duarte : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Duarte : City of Hope

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

El Cajon :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Fountain Valley : Compassionate Care Research Group, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Fullerton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Gilroy :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Hollywood : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

La Jolla :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

La Jolla :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

La Jolla : Moores Cancer Center University of California, San Diego, Site #099 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

La Mesa :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Loma Linda : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Long Beach :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Los Angeles :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Los Angeles : UCLA Department of Medicine

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Los Angeles : USC Norris Comprehensive Cancer Center

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Los Angeles : Cedars-Sinai Medical Center Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Los Angeles : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Los Angeles : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Los Angeles : University of Southern California/Norris Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Los Angeles : Hao Wei Zhang MD, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Modesto :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Northridge :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Oceanside :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Orange : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oxnard : Ventura County Hematology-Oncology Specialists

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Pasadena :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Pasadena : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Redondo Beach : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Redondo Beach :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Riverside : Compassionate Cancer Care Medical Group, Inc.

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Sacramento : University of California Davis

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sacramento : UC Davis Comprehensive Cancer Center

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Sacramento : UC Davis Comprehensive Cancer Center

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Sacramento : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

San Diego : Kaiser Permanente, Site #208 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

San Diego :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer, Adenocarcinoma or Pancreatic Neoplasms

San Francisco : University of California San Francisco

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

San Francisco :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

San Jose : Global Cancer Research Institute

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

San Luis Obispo :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Santa Barbara :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Santa Maria :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Santa Monica : University of California, Los Angeles Medical Center (UCLA)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Santa Monica :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Whittier :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Whittier : Innovative Clinical Research Institute

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Whittier :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Colorado

Aurora : University of Colorado Cancer Center

A clinical research study of Ponatinib

Aurora :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Aurora :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Aurora :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Aurora : University of Colorado Cancer Center, Site #015 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Aurora : University of Colorado

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Aurora : University of Colorado Anschutz Medical Campus

Patients are needed to participate in a clinical research study of IMMU-132

Colorado Springs :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Denver : Rocky Mountain Cancer Centers

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Denver :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Denver :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Grand Junction :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Lone Tree :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Connecticut

New Haven : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

New Haven : Yale Cancer Center (Site 033) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

New Haven : Yale University School of Medicine

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New Haven : Yale University

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Southington :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Trumbull :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Delaware

Newark : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Newark : Christina Care Health System

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Newark : Helen F. Graham Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Newark :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Florida

Altamonte Springs :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Boca Raton : Lynn Cancer Institute/Boca Raton Regional Hospital

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Boca Raton : Lynn Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boca Raton : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boca Raton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Deerfield Beach : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Fort Myers :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Fort Myers : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Fort Myers : Florida Cancer Specialists Updated

Patients are needed to participate in a clinical research study to evaluate Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Gainesville : University of Florida

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Jacksonville :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Jacksonville : Baptist Cancer Institute

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lake Worth : Cancer Center of South Florida, Site #204 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Lakeland : Lakeland Regional Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Miami :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Miami : UM Sylvester Comprehensive Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Miami : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Miami :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

New Orleans : Ochsner Health System/The Gayle and Tom Benson Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Ocala : Ocala Oncology Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Ocala :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Orange Park :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Orlando : Florida Hospital

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Orlando :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Orlando : Florida Hospital Cancer Institute Memorial System

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Orlando : MD Anderson Cancer Center Orlando

Patients are needed to participate in a clinical research study of IMMU-132

Pembroke Pines : Memorial Cancer Institute Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Sarasota : Florida Cancer Specialists / Sarah Cannon Research Institute

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

St. Petersburg :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

St. Petersburg :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

St. Petersburg :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

St. Petersburg : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St. Petersburg : Florida Cancer Specialists and Research Institute Updated

Patients are needed to participate in a clinical research study to evaluate Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Tampa :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Tampa :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Tampa :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical trial seeking patients for a research study for the treatment of Prostate Cancer

Tampa : H. Lee Moffitt Cancer Center (Site 017) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Tampa : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tampa : Moffitt Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Georgia

Savannah : Memorial University Medical Center

RTOG 1010: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

Athens :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Atlanta :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Atlanta : Piedmont Hospital Research Institute Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Atlanta : Winship Cancer Institute of Emory University, Site #058 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Atlanta : Northside Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Atlanta : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Atlanta : Emory University Winship Cancer Institute

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Atlanta :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Augusta : Georgia Regents University Cancer Center

A clinical research study of ADXS11-001, High Dose HPV+ Cervical Cancer

Augusta : Georgia Regents University

Patients are needed to participate in a clinical research study of Nab-Paclitaxel, Gemcitabine and Indoximod to evaluate Metastatic Pancreatic Adenocarcinoma or Metastatic Pancreatic Cancer

Marietta : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Marietta :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Maron :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Rome :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Illinois

Arlington Heights : Illinois Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Arlington Heights :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Chicago : University of Chicago

A clinical research study for the treatment of Adenocarcinoma, Gastro-Esophageal Adenocarcinoma

Chicago : University of Chicago Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer, Adenocarcinoma or Pancreatic Neoplasms

Chicago : University of Chicago (Site 001) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Chicago : University of Chicago

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chicago : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Decatur : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Effingham : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Evanston : Northshore University Health System

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Evanston : Northshore University Healthsystem Research Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Harvey :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Niles : Oncology Specialists, S.C.

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Niles :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Springfield : Simmons Cancer Institute

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Indiana

Goshen : Indiana University Health Goshen Center for Cancer Care Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Goshen : IU Health Goshen Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Goshen :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Indianapolis : Saint Francis Medical Group

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Indianapolis :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Indianapolis : Call for Information (Investigational Site 0011) Updated

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Indianapolis : IU Simon Cancer Center

Patients are needed to participate in a clinical research study evaluating porfimer sodium, endoscopic ultrasonography, photodynamic therapy and gemcitabine hydrochloride for the treatment of Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas or Stage III Pancreatic Cancer

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Indianapolis : Investigative Clinical Research of Indiana, LLC

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Lafayette :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Terre Haute : RHHP/Hope Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Iowa

Ames :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Ames : McFarland Clinic Oncology

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Kansas

Topeka :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Wichita : Cancer Center of Kansas

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Kentucky

Ashland :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Louisville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Louisville : CBC Group Consulting in Blood Disorders and Cancer, PSC

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Paducah : Western Kentucky Hematology and Oncology Group

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Louisiana

Marrero : West Jefferson Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Marrero : Crescent City Research Consortium

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Marrero :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

New Orleans :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

New Orleans : Ochsner Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Maine

Scarborough :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Maryland

Annapolis :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Baltimore : Medstar Research Institute

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Baltimore :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Baltimore :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A clinical trial to evaluate treatments using CRS-207, GVAX, nivolumab and CY for patients with Previously Treated Metastatic Adenocarcinoma of the Pancreas

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 1/Phase 2 clinical study for patients with Resectable Pancreatic Adenocarcinoma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Bethesda : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Bethesda :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Easton : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Rockville :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Massachusetts

Boston : Dana Farber Cancer Institute Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Boston :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Boston :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Boston : Dana Farber Cancer Institute

A clinical trial seeking patients for a research study of LY2875358 and Ramucirumab

Boston : Dana Farber Cancer Institute Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Boston : Dana Farber Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Massachusetts General Hospital Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Beth Israel Deaconess Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Boston : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boston : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Boston : Massachusettes General Hospital

Patients are needed to participate in a clinical research study of IMMU-132

Worcester : Reliant Medical Group

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Worcester : Reliant Medical Group

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Worcester :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Michigan

Ann Arbor : University of Michigan

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Ann Arbor : University of Michigan Updated

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Ann Arbor :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Detroit : Henry Ford Health System

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Detroit : Karmanos Cancer Institute

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Detroit : Karmanos Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Detroit : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Detroit : Wayne State University/Karmanos Cancer Institute

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Detroit :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Farmington Hills :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Lansing : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Minnesota

Rochester : Mayo Clinic (Site 044) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Rochester : Mayo Clinic

A Phase 1 clinical study for patients with Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer or Pancreatic Adenocarcinoma

Rochester : Mayo Clinic - Rochester

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

St. Louis Park :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

St. Louis Park : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Woodbury :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Missouri

Bridgeton : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Jefferson City :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Kansas City :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

St. Louis :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

St. Louis : Saint Louis University Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

St. Louis : Washington University in St. Louis

Patients are needed to participate in a clinical research study of Nab-Paclitaxel, Gemcitabine and Indoximod to evaluate Metastatic Pancreatic Adenocarcinoma or Metastatic Pancreatic Cancer

St. Louis :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Nebraska

Lincoln :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Omaha : Nebraska Methodist Hospital

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Omaha :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Omaha : Nebraska Cancer Specialists, Methodist Estabrook Cancer Center Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Omaha : UNMC Eppley Cancer Center at the University of Nebraska Medical Center

A clinical trial seeking patients for a research study of ADH-1, cisplatin, gemcitabine hydrochloride and laboratory biomarker analysis

Omaha : Methodist Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Omaha :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Omaha : Nebraska Methodist Hospital Updated

Patients are needed to participate in a clinical research study to evaluate Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Nevada

Henderson :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Las Vegas :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Las Vegas :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

New Hampshire

Lebanon : Dartmouth Hitchcock Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lebanon : Dartmouth-Hitchcock Norris Cotton Cancer Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

New Jersey

Basking Ridge : Memoral Sloan Kettering Cancer Center Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Basking Ridge : Memorial Sloan Kettering Cancer Center at Basking Ridge Updated

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Cherry Hill : Regional Cancer Care Associates/Cherry Hill Division, LLC.

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Cherry Hill : Regional Cancer Care Associates

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

East Brunswick : Regional Cancer Care Associates

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Hackensack : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Livingston : Saint Barnabas Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Livingston : Saint Barnabas Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Morristown : Regional Cancer Care Associates/ Carol G. Simon Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Pompton Plains : Regional Cancer Care Associates

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Somerville : Regional Cancer Care Associates/ Somerset Division

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Somerville : Regional Cancer Care Associates

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Sparta : Regional Cancer Care Associates/Sparta Division

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Sparta : Regional Cancer Care Associates

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Voorhees :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

New Mexico

Farmington :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

New York

Albany :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Binghamton :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Binghamton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Birmingham :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Bronx : Montefiore Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Bronx :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Bronx : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Bronx :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Buffalo : Roswell Park Cancer Institute Updated

A clinical trial to evaluate treatments using Regorafenib and laboratory biomarker analysis for patients

Buffalo : Roswell Park Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Buffalo : Roswell Park Cancer Institute Updated

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Commack : Memorial Sloan-Kettering Cancer Center @ Suffolk Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Commack : Memorial Sloan Kettering Cancer Center at Commack Updated

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Fresh Meadows :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Hudson :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Hudson :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Jamaica : Queens Cancer Center of Queens Hospital Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Johnson City : Broome Oncology, LLC

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Johnson City :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Lake Success : Clinical Research Alliance

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lake Success : NYU Langone Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New Hyde Park : Long Island Jewish Medical Center Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

New York : Memorial Sloan Kettering Cancer Center Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma or Distal Esophageal Adenocarcinoma

New York : Memorial Sloan Kettering Cancer Center 1275 York Avenue Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

New York : Memorial Sloan Kettering Cancer Center

A clinical trial seeking patients for a research study of LY2875358 and Ramucirumab

New York : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

New York : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

New York : Memorial Sloan Kettering Cancer Center Updated

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

New York : Columbia University Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York : Weill Cornell/New York Presbyterian Hospital

Patients are needed to participate in a clinical research study of IMMU-132

New York :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Nyack :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Rochester : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Rochester : University of Rochester Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rochester : University of Rochester

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Rockville Centre : Memorial Sloan Kettering at Mercy Medical Center Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Rockville Centre : Memorial Sloan Kettering Cancer Center at Mercy Medical Center Updated

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Sleepy Hollow : Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Sleepy Hollow : Memorial Sloan Kettering Cancer Center Sleepy Hollow Updated

A clinical trial to evaluate treatments using Regorafenib for patients with Metastatic Colorectal Adenocarcinoma

Syracuse : State University of New York Upstate Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Syracuse : SUNY Upstate Medical University

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

North Carolina

Chapel Hill : Lineberger Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Chapel Hill : UNC Health Care; N.C. Cancer Hospital Infusion/Inpatient Pharmacy (CHIP) (Site 032) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Chapel Hill : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Charlotte : Carolinas Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Charlotte : Novant Health Presbyterian Medical Center, Site #205 Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Levine Cancer Institute-Concord/Clinical Trials (Site 056) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Novant Health Presbyterian Medical Center Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Charlotte : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Durham :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Wilmington : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Winston-Salem : Novant Health Oncology Specialists/Forsyth Memorial Hospital

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Winston-Salem : Wake Forest Baptist Health

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Winston-Salem : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Winston-Salem :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Ohio

Canton :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Canton :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Canton :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Canton : Gabrail Cancer Center

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Cincinnati :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Cincinnati :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Cincinnati :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Cincinnati :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Cincinnati : Oncology Hematology Care Inc.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Cleveland :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Cleveland : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Cleveland : Cleveland Clinic Foundation

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

A clinical trial to evaluate treatments using panitumumab, irinotecan hydrochloride, fluorouracil and leucovorin calcium for patients

Columbus : Ohio State University Comprehensive Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Columbus : Ohio State University Medical Center Updated

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Columbus :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Middletown :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Toledo :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Oklahoma

Lawton : Cancer Centers of Southwest Oklahoma

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Oklahoma City : Oklahoma University

A clinical research study of MORAb-066

Oklahoma City : University of Oklahoma Peggy and Charles Stephenson Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tulsa : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oregon

Corvallis : Samaritan Hematology & Oncology Consultants

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Eugene :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Portland : Oregon Health and Science University

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Portland :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Portland :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Portland : Oregon Health and Sciences University

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Portland : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Portland : Providence Health & Services

Patients are needed to participate in a clinical research study of DRibble Vaccine for Prostate Cancer Patients

Portland :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Pennsylvania

Hershey : Penn State/Milton S Hershey Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Philadelphia : Thomas Jefferson University

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Philadelphia : University of Pennsylvania

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Philadelphia : Thomas Jefferson University

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study of Enzalutamide, Goserelin acetate, Leuprolide acetate and Radiation therapy

Pittsburgh : Allegheny Singer Research Institute

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Pittsburgh : University of Pittsburgh Cancer Institute Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Pittsburgh : UPMC Cancer Pavillion

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Pittsburgh : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

PIttsburgh : Allegheny Singer Research Institute- West Penn

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Pittsburgh : University of Pittsburgh Medical Center

Patients are needed to participate in a clinical research study of Nab-Paclitaxel, Gemcitabine and Indoximod to evaluate Metastatic Pancreatic Adenocarcinoma or Metastatic Pancreatic Cancer

Sayre : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

South Carolina

Charleston :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Charleston : Medical Universtiy of South Carolina (MUSC)

A clinical trial seeking patients for a research study for the treatment of Solid Tumors

Charleston : Medical University of South Carolina

Patients are needed to participate in a clinical research study for the treatment of Metastatic Pancreatic Adenocarcinoma

Charleston :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Easley :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Greenville :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Greer :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Spartanburg :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Sumter :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

South Dakota

Watertown : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tennessee

Chattanooga :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Chattanooga :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Chattanooga : Tennessee Oncology - Chattanooga

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chattanooga : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Chattanooga : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Germantown : The Jones Clinic

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Knoxville :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Knoxville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Knoxville : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Knoxville : The University of Tennessee Medical Center

Patients are needed to participate in a clinical research study of BBI608, Nab-paclitaxel and Gemcitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Knoxville : Center for Biomedical Research

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Memphis :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Nashville : Tennessee Oncology

A clinical research study of MORAb-066

Nashville :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Nashville :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Nashville : Sarah Cannon Research Institute Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Nashville :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Nashville :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Nashville : Tennessee Oncology PLLC

A clinical trial seeking patients for a research study of LY2875358 and Ramucirumab

Nashville : Sarah Cannon Cancer Center

A clinical trial seeking patients for a research study of LY2875358 and Ramucirumab

Nashville : Tennessee Oncology

A clinical trial to evaluate treatments using MMB, Capecitabine and Oxaliplatin for patients with Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

Nashville : Vanderbilt-Ingram Cancer Center

A clinical trial to evaluate treatments using panitumumab, irinotecan hydrochloride, fluorouracil and leucovorin calcium for patients

Nashville : Vanderbilt University Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Tennessee Oncology PLLC

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : Vanderbilt-Ingram Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Texas

Amarillo : Texas Oncology, P.A.

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Arlington :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Arlington : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Arlington : Texas Health Physicians Group

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Arlington :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Beaumont : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Beaumont :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Bedford :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Dallas :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Dallas : Baylor University Medical Center at Dallas

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Dallas :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Dallas : Texas Oncology

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Dallas : UT Southwestern Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Dallas : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dallas : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Denton :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

El Paso :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

El Paso : Texas Tech University Health Sciences Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

El Paso :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Fort Worth :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Fort Worth :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Fort Worth : Center for Cancer and Blood Disorders

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Fort Worth :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Galveston : University of Texas Medical Branch

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Abraxane for the treatment of Colorectal Cancer or Cancer of Gastrointestinal Tract

Houston : Department of Investigator Cancer Therapeutics, University of Texas, MD Anderson Cancer Center

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

Houston :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Houston : UT MD Anderson Cancer Center (Site 005) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Everolimus and LDE 225 for patients with Esophageal Cancer

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Gastrointestinal Cancer

Houston : Baylor Clinic

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Houston : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Houston : Westchase Clinical Associates/Westchase Oncology Center

Patients are needed to participate in a clinical research study of Glufosfamide and Fluorouracil to evaluate Second Line Metastatic Pancreatic Adenocarcinoma

Longview : Texas Oncology, P.A./Longview Cancer Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Lubbock : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Paris :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Plano :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Plano :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Round Rock :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

San Antonio : Cancer Therapy and Research Center (CTRC), The University of Texas Health Science Center at San Antonio

A clinical research study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody for the treatment of Malignant Solid Tumors

San Antonio : South Texas Accelerated Research Therapeutics Updated

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

San Antonio :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

San Antonio : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

San Antonio : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

San Antonio :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Tyler :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Tyler : Texas Oncology P.A. - Tyler

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Waco :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Utah

American Fork :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Bountiful :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Murray :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Ogden :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Provo :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Salt Lake City :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Salt Lake City : Huntsman Cancer Center

Patients are needed to participate in a clinical research study of Nab-Paclitaxel, Gemcitabine and Indoximod to evaluate Metastatic Pancreatic Adenocarcinoma or Metastatic Pancreatic Cancer

Salt Lake City :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

St. Lake City :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

West Jordan :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Virginia

Charlottesville : University of Virginia

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Fairfax : Virginia Cancer Specialists, PC

A clinical trial to evaluate treatments using MMB, Capecitabine and Oxaliplatin for patients with Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

Newport News :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Richmond : Virginia Commonwealth University Updated

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Roanoke :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Roanoke :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Washington

Everett : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Seattle :

A clinical study for patients with Lung Cancer, NSCLC or Lung Adenocarcinoma

Seattle : Virginia Mason Medical Center

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Seattle : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seattle : Swedish Cancer Institute (Site 211) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seattle : Seattle Cancer Care Alliance

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seattle : Virginia Mason Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seattle : Virginia Mason Cancer Center

Patients are needed to participate in a clinical research study of IMMU-132

Seattle :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Spokane Valley : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tacoma : Northwest Medical Specialties Updated

A Phase 2 clinical study for patients with Metastatic Pancreatic Ductal Adenocarcinoma

Tacoma : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vancouver : Northwest Cancer Specialists, PC

A clinical research study of nab-paclitaxel and Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Vancouver :

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

West Virginia

Morgantown : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wisconsin

Green Bay : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Green Bay : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madison : University of Wisconsin Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer, Adenocarcinoma or Pancreatic Neoplasms

Madison : University of Wisconsin

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madison :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Milwaukee : Medical College of Wisconsin Updated

A clinical trial seeking patients for a research study for the treatment of Gastroesophageal Junction Adenocarcinoma or Gastric Cancer

Argentina

Australia

Australian Capital Territory :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Bentleigh East : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Bentleigh East : Monash Medical Centre Moorabbin Campus

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Camperdown : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Camperdown : Chris O'Brien Lifehouse Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Fitzroy : St Vincent's Hospital Melbourne (Site997) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Frankston : Peninsula & South Eastern Haematology Group (Site 994) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Garran : The Canberra Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gosford : Central Coast Cancer Centre, Gosford Hospital (Site 402) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Heidelberg : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heidelberg : Austin Health, Austin Hospital ((Site 999) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Herston : Royal Brisbane & Women's Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Kogarah : The St George Hospital, Cancer Care Center (Site 403) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Kurralta Park : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Malvern : Cabrini Hospital Malvern

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New South Wales :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

South Brisbane : Icon Cancer Care South Brisbane

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St Leonards : Northern Cancer Institute, St Leonards

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St. Leonards : Royal North Shore Hospital Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Subiaco : St John of God Hospital Subiaco

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sydney : Prince of Wales Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Woolloongabba : Priness Alexandra Hospital, Cancer Services (Site 942) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Austria

Graz : Medizinische Universität Graz

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Innsbruck : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Innsbruck : Universitätsklinikum Innsbruck

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Krems : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kufstein : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Linz :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Linz : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Linz : A.ö. Krankenhaus der Elisabethinen

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Linz : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Linz : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Salsburg :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Salzburg : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Salzburg : St.-Johanns-Spital, Universitatsklinik fur Pneumologie/Lungenheilkunde (Site 627) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Salzburg : Salzburger Landeskliniken

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Vienna : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Vienna : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wels : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Wels : Klinikum Wels-Grieskirchen GmbH

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wels : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Wien : SMZ Baumgartner Hohe Otto Wagner Spital, Onkologische Ambulanz+Tagesklinik (Site 612) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Wien : Kaiser Franz Josef Spital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wien : Medizinische Universität Wien

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Belgium

Aalst : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Brussels : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Brussels : Hôpital Erasme

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Brussels : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bruxelles : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Charleroi : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Charleroi : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Edegem : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Edegem : UZ Antwerpen

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gent : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Gent : University Hospital Gent Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Gent : UZ Gent

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Haine St. Paul : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Jette : AZ VUB

A Phase 2 clinical study for patients with Lung Neoplasms, Non-Small Cell Lung Cancer or Adenocarcinoma, Bronchiolo-Alveolar

Leuven : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Leuven : UZ Leuven

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Liège : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Liège : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Roeselare : H.-Hartziekenhuis Roeselare-Menen vzw (Site 617) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Yvoir : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bosnia and Herzegovina

Banja Luka : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Banja Luka : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Mostar : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sarajevo : Synta Pharmaceuticals Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Tuzla : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zenica : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bulgaria

Plovdiv : Complex Oncology center - Plovdiv EOOD, Department of medical oncology and oncology diseases in hematology

Patients are needed to participate in a clinical research study evaluating CVac for the treatment of Pancreatic Carcinoma Stage I or Pancreatic Carcinoma Stage II

Plovdiv : MHAT Central Onco Hospital OOD, Department of Medical Oncology

Patients are needed to participate in a clinical research study evaluating CVac for the treatment of Pancreatic Carcinoma Stage I or Pancreatic Carcinoma Stage II

Sofia : Specialized Hospital for Active Treatment of Oncology Diseases -

Patients are needed to participate in a clinical research study evaluating CVac for the treatment of Pancreatic Carcinoma Stage I or Pancreatic Carcinoma Stage II

Canada

Calgary : Tom Baker Cancer Centre

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Edmonton : Cross Cancer Institute

A clinical research study of Irinotecan-Capecitabine-Oxaliplatin for the treatment of Gastrointestinal Neoplasm or Gastric Adenocarcinoma

Edmonton : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Montreal : Jewish General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : Montreal General Hospital

A clinical research study of Androgen suppression plus radiation therapy for the treatment of Adenocarcinoma of the Prostate

Montreal : CHUM Hôpital Saint-Luc

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Montreal : Jewish General Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Montreal : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Oshawa :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Ottawa : The Ottawa Hospital Cancer Centre (Site 131) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Toronto : Princess Margaret Cancer Center Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Toronto : Princess Margaret Hospital

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

Toronto : Princess Margaret Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chile

Santiago :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Santiago : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Santiago : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Santiago : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Vitacura :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

China

Beijing : Cancer Hospital, Chinese Academy of Medical Science

A clinical research study of Icotinib and Placebo for the treatment of EGFR Positive Non-small Cell Lung Cancer or Adenocarcinoma

Beijing : Chinese People's Liberation Army (PLA) General Hospital

A clinical trial seeking patients for a research study for the treatment of EGFR Positive Non-small Cell Lung Cancer or Adenocarcinoma

Beijing : Cancer Hospital, Chinese Academy of Medical Sciences

A Phase 2 clinical study for patients with Adenocarcinoma of the Gastroesophageal Junction or Esophageal Carcinoma

Beijing : Peking Unicersity Cancer Hospital

A Phase 3 clinical study for patients with Advanced Gastric Carcinoma

Beijing : Beijing Cancer Hospital

Patients are needed to participate in a clinical research study of SOX sequential S-1 to evaluate Biliary Tract Cancer, Periampullary Adenocarcinoma or Pancreatic Cancer

Guangzhou : Sun Yat-sen University Cancer Center

A clinical trial to evaluate treatments using S-1, Oxaliplatin and Cisplatin for patients with Gastric Cancer

Croatia

Pula : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zagreb : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Czech Republic

Hradec Kralove : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Hradec Kralove : Fakultni nemocnice Hradec Kralove

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Liberec : Krajska nemocnice Liberec, a.s.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Olomouc : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Ostrava : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prague : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Praha 2 : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Zlin : Krajska nemocnice T. Bati a.s.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Denmark

Ålborg : Aalborg Universitetshospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Copenhagen : Rigshospitalet

A clinical trial to evaluate treatments using KPT-330 for patients with Solid Tumor

DK 2730 Herlev : Herlev Hospital (Site 614) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Herlev : Herlev Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Odense C : Odense University Hospital (Site 615) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Finland

Helsinki : Helsingin Yliopistollinen Keskussairaala

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Kuopio : Kuopio University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Oulu : Oulu Univerity Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Tampere : Tampereen yliopistollinen sairaala

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tampere : University of Tampere

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Turku : Turun Yliopistollinen Keskussairaala

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Turku : Department of Oncology and Radiotherapy, turku University Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

Vaasa : Vaasa Distric Hospital

Patients are needed to participate in a clinical research study evaluating docetaxel and capecitabine for the treatment of Stomach Neoplasms

France

Angers : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Angers cedex 12 : CHU Angers

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Bordeaux : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Clichy : Hopital Beaujon Updated

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma Metastatic

Creteil : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Créteil : Hopital Henri Mondor

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gap : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Grenoble : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lille : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Lille : CHRU Lille

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lille : Centre Oscar Lambret

Patients are needed to participate in a clinical research study of Aflibercept-FOLFIRI to evaluate Metastatic Colorectal Cancer

Lyon : Hopital prive Jean Mermoz

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lyon Cedex 06 : Groupement Hospitalier Edouard Herriot

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lyon Cedex 08 : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Lyon cedex 8 : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Marseille cedex 5 : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Paris : Hôpital Européen Georges Pompidou

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Paris : Groupe Hospitalier Pitie Salpetriere

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Paris : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Poitiers : CHRU de Poitiers La Miletrie

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Reims : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Rennes : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Rouen : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Saint Herblain : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Strasbourg : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Villefranche-sur-Saone : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Villejuif : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Germany

Bad Nauheim : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Berlin : Evangelische Lungenklinik Berlin

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Berlin : Evangelische Lungenklinik Berlin (Site 588) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Berlin : Charité - Universitätsmedizin Berlin

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Berlin : Charité - Universitätsmedizin Berlin

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Cologne : University of Cologne / LCGC

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Cologne : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Dresden : Universitätsklinikum Carl Gustav Carus an der TU Dresden

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Essen : Kliniken Essen Mitte

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Frankfurt : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Frankfurt a.M. : Universitätsklinikum Frankfurt - Medizinische Klinik II

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Frankfurt/Oder : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Frechen : Praxis Internistischer Onkologie und Hämatologie Frechen

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Freiburg : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Friedrichshafen : Praxis für Innere Medizin Droettle Helmut

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Greifswald : Universität Greifswald

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Großhansdorf : LungenClinic Großhansdorf

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Grosshansdorf : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Halle : Krankenhaus Martha Marie Halle (Site 572) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hamburg : Research Site

A clinical trial to evaluate treatments using AMG 211 for patients with Gastrointestinal Cancer, Adenocarcinoma

Hamburg : Universitätsklinikum Hamburg Eppendorf

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Hamburg : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Hamburg : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Heidelberg : Thoraxklinik Heidelberg

A clinical trial seeking patients for a research study for the treatment of Lung Cancer, Adenocarcinoma or NSCLC

Heidelberg : Thoraxklinik-Heidelberg gGmbH, Innere Medizin - Onkologie (Site 586) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hemer : Lungenklinik Hemer, Zentrum fur Pneumologie und Thoraxchirurgie (Site 620) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hessen : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Homburg : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kassel : Klinikum Kassel GmbH, Klinik fur Onkologie und Hamatologie (Site 573) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Koln : Kliniken der Stadt Koln gGmbH, Lungenkrebszentrum Koln-Merheim (Site 626) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Köln : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Köln : Praxis Internistischer Onkologie und Hämatologie Köln

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Leipzig : Prof. Dr. F. Lordick

A clinical research study of catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel and Fluorouracil, leucovorin, oxaliplatin, docetaxel for the treatment of Gastric Adenocarcinoma With Peritoneal Carcinomatosis, Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis or Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis

Leipzig : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Leipzig : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Leubeck : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Mainz : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Mainz : Universitätsmedizin der Johannes Gutenberg-Universität Mainz

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Mainz : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Muenchen : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Muenster : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Munchen : LMU - Klinikum der Universitat Munchen, Campus Innenstadt, Medizinische Klinik V, Pneumologie (Site 609) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

München : Research Site

A clinical trial to evaluate treatments using AMG 211 for patients with Gastrointestinal Cancer, Adenocarcinoma

München : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

München : Klinikum Neuperlach

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Offenbach : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ulm : Research Site

A clinical trial to evaluate treatments using AMG 211 for patients with Gastrointestinal Cancer, Adenocarcinoma

Würzburg : Universitätsklinikum Würzburg/Comprehensive Cancer Center Mainfranken

A clinical trial seeking patients for a research study for the treatment of Ductal Adenocarcinoma of the Pancreas

Würzburg : Universitätsklinikum Würzburg

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Greece

Athens : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Athens : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Heraklion - Crete : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Ioannina : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Piraeus : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Hong Kong

Hong Kong : Queen Mary Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Hong Kong : Queen Mary Hospital, Department of Clinical Oncology (Site 986) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Hong Kong : Queen Mary Hospital, Division of Respiratory and Critical Care Medicine (Site 973) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Kowloon : Queen Elizabeth Hospital, Department of Clinical Oncology (Site 987) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Pok Fu Lam :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Sha Tin :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Hungary

Budapest : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Budapest : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Budapest : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Budapest : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Budapest : Uzsoki Utcai Kórház

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Budapest : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Budapest : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Debrecen : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Debrecen : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Debrecen : Debreceni Egyetem Orvos-és Egészségtudományi Centrum

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Deszk : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Deszk : Synta Pharmaceuticals Investigative Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Farkasgyepu : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Gyor : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Gyula : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kaposvar : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Kecskemet : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Matrahaza : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Pecs : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Szekesfehervar : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Szekesfehervar : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szekszard : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Szolnok : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Szombathely : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Tatabánya : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Torokbalint : Updated

A clinical research study for the treatment of Lung Adenocarcinoma

Ireland

Dublin : Saint Vincent's University Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Israel

Haifa : Rambam medical Center

A clinical trial to evaluate treatments using Capecitabine (Xeloda) for patients with Adenocarcinoma Clear Cell

Hod Hasharon : Merck Sharp & Dohme Co. Ltd. Updated

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Italy

Ancona : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Ancona : Az Osp University Ospedali Riuniti umberto I GM Lancisi Gsalesi

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Aviano : S.O.C. Oncologia Medica A, Centro di Riferimento Oncologico, I.R.C.C.S., Istituto Nazionale Tumori (Site 624) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Aviano : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bologna : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Brescia : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Brindisi : U.O.C. Oncologia Medica, Ospedale A. Perrino, Presidio Ospedaliero Di Summa - Perrino, Azienda Sanitaria Locale di Brindisi (Site 629) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Cremona : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Firenze : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Firenze : Azienda Ospedaliera Universitaria Careggi

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Genova : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Genova : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Meldola : Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Meldola (FC) : U.O. Oncologia Medica, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)_IRCCS (Site 575) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Milano : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Milano : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Milano : Divisione Oncologia Toracica, Istituto Europeo di Oncologia, Istituto di Ricovero e Cura a Carattere Scientifico (Site608) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Milano : Dipartimento di Oncologia Medica Ospedale San Raffaele, Istituto di Ricovero e Cura a Carattere Scientifico (Site 578) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Milano : Ospedale San Raffaele S.r.l.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Milano : Azienda Ospedaliera Niguarda Cà Granda

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Milano : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Napoli : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Napoli :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Parma : Struttura Complessa Oncologia Medica Azienda Ospedaliero-Universitaria di Parma (Site 607) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Perugia : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Pisa : Cisanello Hospital, Division of Diagnostic Imaging and Intervention

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Pisa : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Pisa : Azienda Ospedaliero Universitaria Pisana

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Reggio Emilia : Arcispedale Santa Maria Nuova

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Roma : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Roma : Istituto Nazionale Tumori Regina Elena

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rozzano : Istituto Clinico Humanitas

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rozzano MI : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

San Giovanni Rotondo : Ospedale Casa Sollievo Della Sofferenza IRCCS

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Terni : Azienda Ospedaliera S Maria Di Terni

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Torino : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Udine : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Verona : Azienda Ospedaliera Universitaria Integrata Di Verona

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Japan

Chuo-ku :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Kobe :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Nagoya :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Natori :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Osaka-Sayama :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Korea, Republic of

Busan : Pusan National University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Busan : Gosin University Gospel Hospital

Patients are needed to participate in a clinical research study of Erlotinib and Silybin-phytosome to evaluate Carcinoma, Non-Small-Cell Lung

Daegu : Kyungpook National University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Daegu : Kyungpook National University Medical Center

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Goyang-si : Inje University Ilsan Paik Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Goyang-si : National Cancer Center (Site 916) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Goyang-si : National Cancer Center

Patients are needed to participate in a clinical research study evaluating Gefitinib, Placebo and Pemetrexed plusCIsplatin for the treatment of Non Small Cell Lung Cancer or Adenocarcinoma

Goyang-si, Gyeonggi-do : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Hwasun : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Hwasun-gun :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Incheon : Inha University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seongnam-si :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Seoul : Severance Hospital, Yonsei University Health System

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Seoul National University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Samsung Medical Center

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : The Catholic University of Korea, Seoul St.Mary's Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : Korea University Anam Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Seoul : MSD Korea LTD Updated

A clinical trial seeking patients for a research study for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Seoul : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Seoul : Asan Medical Center (Site 917) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Seoul National University Hospital (Site 915) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : The Catholic University of Korea Seoul St. Mary's Hospital (Site 938) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Severance Hospital, Yonsei University Health System (Site 913) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Seoul : Asan Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seoul : Seoul National University Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seoul : Samsung Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seoul :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Malaysia

Kuala Lumpur : University Malaya Medical Centre

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Negeri Sembilan : Nilai Medical Centre

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Mexico

Netherlands

Amsterdam : Research Site

A clinical trial to evaluate treatments using AMG 211 for patients with Gastrointestinal Cancer, Adenocarcinoma

Amsterdam : VU Medical Center (Site 948) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Amsterdam : The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital (Site 579) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Amsterdam : Academic Medical Center

Patients are needed to participate in a clinical research study to evaluate Barrett'S-associated Dysplasia or Intramucosal Adenocarcinoma

Assen : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Groningen : Research Site

A clinical trial to evaluate treatments using AMG 211 for patients with Gastrointestinal Cancer, Adenocarcinoma

Groningen : University Medical Center Groningen (Site 581) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Harderwijk : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Maastricht : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Masstricht : Maastricht UMC+ (Site 580) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Utrecht : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zutphen : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Zwolle : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Peru

Lima : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Lima : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Philippines

Manila : Chinese General Hospital and Medical Center

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Metro Manila : The Medical City

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Quezon City : St. Lukes Medical Center

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

San Juan : Cardinal Santos Medical Center

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Poland

Bialystok : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Bialystok : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Elblag : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Elblag : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Konin : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Lodz : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Olsztyn : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Pilchowice : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Poznan : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Poznan : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Prabuty : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Szczecin : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warsaw : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Warszawa : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Portugal

Lisbao : Hospital Da Luz

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Lisboa : Centro Hospitalar de Lisboa Central

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Porto : Centro Hospitalar de Sao Joao EPE

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Romania

Bucharest : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Bucharest : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj Napoca : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Cluj-Napoca : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Craiova : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Iasi : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Timisoara : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Russian Federation

Krasnodar : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Moscow : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Moscow : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Saint-Petersburg : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Serbia

Belgrade : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Belgrade : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Kragujevac : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nis : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sremska Kamenica : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Singapore

Singapore :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Singapore : National Cancer Centre Singapore, Depart of Medical Oncology (Site 989) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Singapore : OncoCare Cancer Centre (Site 988) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Slovenia

Golnik : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Ljubljana : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Spain

A Coruna : Hospital Teresa Herrera (Site 554) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Alicante : Hospital General Universitario de Alicante (Site 591) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Badalona : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Barcelona :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Barcelona : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Barcelona : Hospital Universitario Quiron Dexeus, Servicio de Oncologia Medica (Site 590) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Barcelona : Hospital Universitari de la Vall d'Hebron Servicio de Oncologia Medica (Site 503) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Barcelona : Hospital Clinic de Barcelona

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Barcelona : Hospital Universitario Vall d'Hebron

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Barcelona : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Barcelona : ACROSS

Patients are needed to participate in a clinical research study evaluating bevacizumab for the treatment of Rectal Neoplasms or Locally Advanced Rectal Adenocarcinoma

Córdoba : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Elche : Hospital General Universitario de Elche

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Fuenlabrada : Hospital Universitario de Fuenlabrada

Patients are needed to participate in a clinical research study evaluating Arm A chemotherapy and arm B chemotherapy for the treatment of Adenocarcinoma of Colon, Adenocarcinoma of Rectum or Metastatic Disease

Instituto Catalan de Oncologia de Hospitalet (ICO) : Instituto Catalan de Oncologia de Hospitalet (ICO)

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

La Coruña : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

L'Hospitalet de Llobregat, Barcelona : Institut Català d'Oncologia

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid : Hospital Universitario La Paz

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Madrid : Hospital Madrid Norte Sanchinarro

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Madrid :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Madrid :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Madrid : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Madrid : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Madrid : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Madrid : Hospital Universitario La Paz (Site 582) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Madrid : Centro Integral Oncológico Clara Campal

A Phase 1 clinical study for patients with Locally Advanced Pancreatic Adenocarcinoma or Metastatic Pancreatic Adenocarcinoma

Madrid : Hospital General Universitario Gregorio Marañón

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Centro Integral Oncologico Clara Campal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario Ramon y Cajal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario 12 de Octubre

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Madrid Norte Sanchinarro

Patients are needed to participate in a clinical research study evaluating Arm A chemotherapy and arm B chemotherapy for the treatment of Adenocarcinoma of Colon, Adenocarcinoma of Rectum or Metastatic Disease

Madrid : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Madrid : Ramon Y Cajal

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Madrid : Hospital 12 de Octubre

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Malaga : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Malaga : Hospital Regional Universitario de Malaga

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Malaga : Hospital Universitario Carlos Haya

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Mataró : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Palma de Mallorca : Hospital Son Llatzer (Site 625) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Pamplona : Complejo Hospitalario de Navarra

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

San Sebastian : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Santander : Hospital Universitario Marques de Valdecilla

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Santander : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Santander : Hospital Universitario Santander

Patients are needed to participate in a clinical research study of NovoTTF-100L and Gemcitabine to evaluate Pancreatic Adenocarcinoma

Santiago de Compostela : Hospital Clinico Universitario de Santiago

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sevilla : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Sevilla : Hospital Universitario Virgen del Rocio (Site 592) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Sevilla : Hospital Virgen del Rocio

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seville :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Valencia : Hospital Clinico Universitario de Valencia (Site 589) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Valencia : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sweden

Goteborg : Sahlgrenska Universitetssjukhuset (Site 758) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Linkoping :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Stockholm : Karolinska Universitetssjukhuset Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Stockholm : Dept. of Oncology-Pathology, Karolinska University Hospital, Solna

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Stockholm : Dept. of Clinical Science, Intervention and Technology, Div. of surgery, Karolinska University Hospital, Huddinge

A clinical trial to evaluate treatments using AXP107-11 for patients with Adenocarcinoma

Uppsala :

A clinical research study of Ruxolitinib, Placebo and Capecitabine for the treatment of Metastatic Pancreatic Adenocarcinoma That is Recurrent

Switzerland

Bern : Inselspital - Universitatsspital Bern Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Winterthur : Kantonsspital Winterthur Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Taiwan

Douliou City : National Taiwan University Hospital, Yun-Lin Branch

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Taichung : Taichung Veteran General Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Taichung : China Medical University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Tainan : National Cheng Kung University (NCKU) Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Tainan City : National Cheng Kung University Hosptial

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Taipei :

A clinical research study of Lenvatinib for the treatment of KIF5B-RET-Positive Adenocarcinoma of the Lung

Taipei : Mackay Memorial Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Taipei City : National Taiwan University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Thailand

Bangkok : Siriraj Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Bangkok : Chulalongkorn University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Pathumthani : Thammasat University Hospital

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

United Kingdom

Aberdeen :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Bangor :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Cardiff : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Edinburgh : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Edinburgh : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Leicester : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Leicester : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

London :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

London : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

London : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

London :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Manchester :

A clinical trial seeking patients for a research study for the treatment of Adenocarcinoma of the Stomach or Gastroesophageal Junction Expressing Guanylyl Cyclase C

Manchester :

A clinical trial seeking patients for a research study for the treatment of Pancreatic Adenocarcinoma

Manchester : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Manchester : The Christie NHS Foundation Trust (Site 725) Updated

A clinical trial to evaluate treatments using AP26113 (90 mg) and AP26113 (90 mg /180 mg) for patients with Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Manchester :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Northwood : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Nottingham : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Nottingham : Nottingham Univeristy Hospitals NHS Trust

Patients are needed to participate in a clinical research study evaluating Iron isomaltoside 1000 for the treatment of Anemia, Esophageal Cancer or Gastric Cancer

Plymouth :

Patients are needed to participate in a clinical research study of Ruxolitinib, Placebo and Capecitabine to evaluate Metastatic Pancreatic Adenocarcinoma

Sheffield : Weston Park Hospital

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Shrewsbury : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Southampton : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Sutton : Research Site Updated

A clinical trial to evaluate treatments using AMG 337 for patients with Stomach Neoplasms

Sutton : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Swindon : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

Truro : Synta Pharmaceuticals Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating Arm A: single agent docetaxel and Arm B: Combination of ganetespib and docetaxel for the treatment of Non-Small-Cell Lung Adenocarcinoma, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV or Non-small Cell Lung Cancer Metastatic

 

Kidney & Urology Foundation of America | 152 Madison Ave, Suite 201 | New York, NY 10016 | 1.800.633.6628
©

About Us | Patient Resources | Professional Resources | Support Us | News & Recent Events | Brochures
Corporate Sponsors | Contact Us | Terms of Use | Privacy Policy

Website Last Modified: October 28, 2010
Donate Today Donate Your Car Join KUFA Now